PG
IPXL

PEAK6 Group’s Impax Laboratories, Inc. IPXL Stock Holding History

PEAK6 Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,700
Closed -$380K – 5207
2017
Q3 		$380K Buy
+18,700
New +$357K ﹤0.01% 2760
2016
Q3 		– Sell
-12,800
Closed -$369K – 4995
2016
Q2 		$369K Buy
+12,800
New +$417K ﹤0.01% 2637
2015
Q4 		– Sell
-18,200
Closed -$641K – 5650
2015
Q3 		$641K Buy
+18,200
New +$820K ﹤0.01% 2648
2015
Q2 		– Sell
-68,700
Closed -$3.22M – 5761
2015
Q1 		$3.22M Buy
68,700
+60,800
+770% +$2.42M 0.02% 938
2014
Q4 		$250K Buy
+7,900
New +$231K ﹤0.01% 3193
2014
Q1 		– Sell
-25,100
Closed -$631K – 5692
2013
Q4 		$631K Buy
+25,100
New +$560K ﹤0.01% 2473

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Group's IPXL Position: Q4 2015 in Review

PEAK6 Group sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 35,069 shares — an estimated $1.24M sold.

PEAK6 Group first reported a position in IPXL in Q3 2015 and held it in 1 quarter. The position peaked at $1.24M in Q3 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

  • PEAK6 Group reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
  • PEAK6 Group sold 35,069 Impax Laboratories, Inc. shares in Q4 2015, an estimated $1.24M.
  • PEAK6 Group first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 1 quarter.
  • PEAK6 Group's Impax Laboratories, Inc. position peaked at $1.24M in Q3 2015.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.